S100A12 is connected with NAFLD-related diseases (including obesity, type 2 diabetes, and inflammation) and may participate in the development of atherosclerosis by mediating the pathophysiological processes of vascular inflammation, calcification, and oxidative stress (22–24). The gene discussed is S100A12; the disease is metabolic dysfunction-associated steatotic liver disease.